Login

Thomas Lienard, CEO, Bone Therapeutics 00:00:00

Share On Facebook Share On Twitter

Thomas Lienard, CEO, Bone Therapeutics presents the company

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Richard Byworth, CEO of Equinix Group, Reflects on a Year of Crypto Innovation and Institutional Adoption
00:10:00
Financial Planning After Divorce with Olivia Lima, PhD | Abundo Wealth | Olivia Lima - Financial Planner of Abundo Wealth
00:00:00
Shield Therapeutics "couldn't be more pleased" with Viatris collaboration - Greg Madison Chief Executive Officer, Shield Therapeutics P
00:10:00
Discover Brussels: Your Gateway to Belgian Charm - Emakina's Ultimate Guide | Brice Le Blevennec, CEO of Emakina group sa
00:10:00
Financial Wellness Month: Essential Tips for a Strong Financial Start in 2024 | Phil Ball, President , Bollin Wealth Management LLC.
00:10:00
Improving American Education by 2030: Removing Mental Obstacles for Teachers
00:10:00
Interview with Oris Minerals: Exploration and Development in Western Australia's Copper Belt
00:10:00
Insight Partners has helped over so many companies turn their vision into reality|Thilo Semmelbauer,Managing Director,Insight Partners
00:10:00
Jim Russo on American Resilience and Staying Invested Through Challenges | James M. Russo , Founder , Altrius Capital Management Inc.
00:10:00
"Charting the Course: Developing a Bold Net Zero Strategy"|CEO,British Land Company PLC
00:10:00
Wan Zulkiflee Wan Ariffin stated that 70% of Petronas' portfolio is comprised of gas.
00:10:00
"Insights into Lodging Sector Recovery and Portfolio Expansion: Interview with Richard from More Hotels and Resorts"|CEO ,Braemar Hotels & Resorts Inc

© 2026 Nehu